Longitudinal prevalence of MAM (cohorts 1 & 3)
defined as the number of MAM diagnoses divided by the total number of monthly visits made
Longitudinal prevalence of SAM (cohorts 1 & 3)
Defined as the number of SAM diagnoses divided by the total number of monthly visits made
Incidence of wasting, MAM and SAM (cohort 1)
defined as the number of new cases of wasting, MAM and SAM recorded during monthly visits among children enrolled at 6 months of age followed monthly until the end of the study (Cohort 1).
Incidence of MAM and SAM (cohort 3)
defined as the number of new cases of MAM and SAM recorded during monthly visits.
prevalence of anemia (cohorts 1 & 3)
Proportion of children with a hemoglobin level below 11g/dl
Mean hemoglobin concentration (cohorts 1 & 3)
Mean hemoglobin concentration measures by hemocue reader
Prevalence of stunting (cohorts 1 & 3)
proportion of children with HAZ <-2 (relative to the 2006 WHO reference)
Height-for-age Z-score (cohorts 1 & 3)
Height-for-age Z-score relative to the 2006 WHO reference
Longitudinal wasting screening coverage (cohorts 1 & 3)
defined as the proportion of children screened (using MUAC, weight-for-height or bilateral edema) in the month prior to the monthly visit. Two sub-outcomes will also be concerned:
Screening coverage by care groups.
Coverage of the family MUAC component, which is the screening performed by a family member in the past month.
Referral rate of positive screenings (cohorts 1 & 3)
defined as the proportion of children who tested positive during the month (according to the mother) and not under CMAM treatment who were referred to the health center or FARNE site.
Enrollment of wasting, MAM, and SAM cases (cohorts 1 & 3)
proportion of cases who tested positive in the month prior to the monthly visit and not under CMAM treatment who were enrolled in a CMAM treatment program.
Linear growth rate (cohorts 1 & 3)
change in height-for-age index per month
Speed of weight growth (cohorts 1 & 3)
change in weight-for-height index per month
Weight gain (cohorts 1 & 3)
weight change per month
MUAC gain (cohorts 1 & 3)
change in MUAC per month
longitudinal prevalence of childhood morbidity, i.e. acute respiratory infections, fever, diarrhea and malaria (cohorts 1 & 3)
the number of diagnoses of daily signs of these morbidities divided by the total number of days reported (1-3 per monthly visit made).
Parental knowledge of nutrition, WASH, and health best practices (cohorts 1 & 3)
expressed as cumulative total and domain scores
Longitudinal prevalence of minimum dietary diversity of infant and young children (cohorts 1 & 3)
the proportion of children who consumed at least 5 of the 8 food groups (including breast milk) the day before the survey.
Longitudinal prevalence of Introduction of (semi) solid and soft complementary foods (cohorts 1 & 3)
the proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods the day before the survey Minimum dietary diversity in children, defined as the proportion of children who consumed at least 5 of the 8 food groups (including breast milk) the day before the survey.
Minimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.
Minimum acceptable diet, defined as the proportion of children with both minimal dietary diversity and minimal meal frequency on the day before the survey.
Consumption of iron-rich or iron-fortified foods in children.
Longitudinal prevalence of minimum meal frequency (cohorts 1 & 3)
the proportion of children who consumed the minimum recommended number of meals for their age on the day before the survey Minimum dietary diversity in children, defined as the proportion of children who consumed at least 5 of the 8 food groups (including breast milk) the day before the survey.
Minimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.
Minimum acceptable diet, defined as the proportion of children with both minimal dietary diversity and minimal meal frequency on the day before the survey.
Consumption of iron-rich or iron-fortified foods in children.
Practices related to water, hygiene and sanitation (cohorts 1 & 3)
Standard USAID indicators related to drinking water source, treatment, storage; hand washing; and sanitation
Vaccination coverage (cohorts 1 & 3)
Proportion of children with complete vaccination for their age
weight-for-height in z-score at enrollment in CMAM (cohort 2)
weight-for-height in z-score (relative to the 2006 WHO reference)
MUAC at enrollment in CMAM (cohort 2)
Mid-upper arm circumference (mm)
Duration of CMAM treatment (cohort 2)
defined as the number of days spent on treatment (enrollment and discharge) in children 6-23 months of age at enrollment, according to health registers
Treatment adherence (cohort 2)
defined as the proportion of cases enrolled for treatment who received timely treatment from dedicated services until recovery
Treatment outcomes (drop-out, death, transfer, non-response rates) (cohort 2)
Among proportion of cases enrolled for treatment
longitudinal prevalence of childhood morbidity (cohort 2)
defined by the number of days for which signs of these morbidities were reported divided by the total number of days observed/reported in the recall periods.